Literature DB >> 16867922

Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.

Lori L Davis1, Elizabeth Frazier, Mustafa M Husain, Diane Warden, Madhukar Trivedi, Maurizio Fava, Paolo Cassano, Patrick J McGrath, G K Balasubramani, Stephen R Wisniewski, A John Rush.   

Abstract

The demographics and clinical features were compared between those with (29.4%) and without concurrent substance use disorder (SUD) in 2541 outpatients with major depression (MDD) enrolled in the Sequenced Treatment Alternatives to Relieve Depression study. Compared to those without SUD, MDD patients with concurrent SUD were more likely to be younger, male, divorced or never married, and at greater current suicide risk, and have an earlier age of onset of depression, greater depressive symptomatology, more previous suicide attempts, more frequent concurrent anxiety disorders, and greater functional impairment (p = 0.048 to <0.0001). They were also less likely to be Hispanic and endorse general medical comorbidities (p = 0.006 and 0.002, respectively).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867922     DOI: 10.1080/10550490600754317

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  31 in total

1.  Genome-wide association study of comorbid depressive syndrome and alcohol dependence.

Authors:  Alexis C Edwards; Fazil Aliev; Laura J Bierut; Kathleen K Bucholz; Howard Edenberg; Victor Hesselbrock; John Kramer; Samuel Kuperman; John I Nurnberger; Marc A Schuckit; Bernice Porjesz; Danielle M Dick
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

2.  Dimensions of religion, depression symptomatology, and substance use among rural African American cocaine users.

Authors:  Brooke E E Montgomery; Katharine E Stewart; Keneshia J Bryant; Songthip T Ounpraseuth
Journal:  J Ethn Subst Abuse       Date:  2014       Impact factor: 1.507

3.  Health Status and Social Characteristics Among the Uninsured Using a Mental Health Free Clinic.

Authors:  Akiko Kamimura; Noel Gardner; Fattima Ahmed; Maziar M Nourian; Kyl Myers; Lenora M Olson
Journal:  J Behav Health Serv Res       Date:  2018-01       Impact factor: 1.505

4.  Prevalence and correlates of alpha-delta sleep in major depressive disorders.

Authors:  Nattapong Jaimchariyatam; Carlos L Rodriguez; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2011-07

5.  Promoting CARE: including parents in youth suicide prevention.

Authors:  Carole Hooven; Elaine Walsh; Kenneth C Pike; Jerald R Herting
Journal:  Fam Community Health       Date:  2012 Jul-Sep

6.  Influence of comorbid alcohol use disorder on treatment response of depressive patients.

Authors:  Eri Hashimoto; Masaya Tayama; Hiromi Ishikawa; Megumi Yamamoto; Toshikazu Saito
Journal:  J Neural Transm (Vienna)       Date:  2014-06-14       Impact factor: 3.575

7.  Substance use disorders in an obsessive compulsive disorder clinical sample.

Authors:  Maria C Mancebo; Jon E Grant; Anthony Pinto; Jane L Eisen; Steven A Rasmussen
Journal:  J Anxiety Disord       Date:  2008-09-06

8.  Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist.

Authors:  Laura E Phelps; Nancy Brutsche; Jazmin R Moral; David A Luckenbaugh; Husseini K Manji; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2008-11-08       Impact factor: 13.382

9.  Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

Authors:  Gonzalo Laje; Roy H Perlis; A John Rush; Francis J McMahon
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

10.  The impact of nonclinical factors on care use for patients with depression: a STAR*D report.

Authors:  T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; Stephen R Wisniewski; A John Rush
Journal:  CNS Neurosci Ther       Date:  2009-08-27       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.